Joel A. FinbloomPhD
Accepting Graduate Students
The Finbloom lab is actively recruiting graduate students! If you are interested, please contact Dr. Finbloom with a cover letter and CV at firstname.lastname@example.org
JA Finbloom#, P Raghavan, M Kwon, BN Kharbikar, MA Yu#, TA Desai#. “Co-delivery of synergistic antimicrobials with polyelectrolyte nanocomplexes to treat bacterial biofilms and lung infections.” bioRxiv. 2021. https://doi.org/10.1101/2021.11.22.469570. #co-corresponding authors
JA Finbloom, B Demaree, AR Abate, TA Desai. “Networks of high aspect ratio particles to direct colloidal assembly dynamics and cellular interactions.” Adv. Funct. Mater. 2020, 30, 2005938. https://doi.org/10.1002/adfm.202005938
JA Finbloom, F Sousa, MM Stevens, TA Desai. “Engineering the drug carrier biointerface to overcome biological barriers to drug delivery.” Adv. Drug Deliv. Rev. 2020, 167, 89-108. https://doi.org/10.1016/j.addr.2020.06.007
JA Finbloom*, IL Aanei*, JM Bernard*, SH Klass, SK Elledge, K Han, T Ozawa, TP Nicolaides, MS Berger, MB Francis. “Evaluation of three morphologically distinct virus-like particles as nanocarriers for convection-enhanced drug delivery to glioblastoma.” Nanomaterials. 2018, 8; 1007-1019. https://doi.org/10.3390/nano8121007 *co-first authors
JA Finbloom, K Han, CC Slack, AL Furst, MB Francis. “Cucurbituril-promoted click chemistry for protein modification.” J. Am. Chem. Soc. 2017, 139; 9691-9697. https://doi.org/10.1021/jacs.7b05164
JA Finbloom, CC Slack, CJ Bruns, K Jeong, DE Wemmer, A Pines, MB Francis. “Rotaxane-mediated suppression and activation of cucurbituril for molecular detection by 129Xe hyperCEST NMR.” Chem. Commun. 2016. 52; 3119-22. https://doi.org/10.1039/C5CC10410F
TJ Moyer*, JA Finbloom*, C Feng, DJ Toft, VL Cryns, SI Stupp. “pH and amphiphilic structure direct supramolecular behavior in biofunctional assemblies.” J. Am. Chem. Soc. 2014. 136; 14746-52. https://doi.org/10.1021/ja5042429 *co-first authors
University of California President’s Fellowship for the Lindau Nobel Laureate Meeting on Interdisciplinary Research. 2021
UCSF Health Innovation Via Engineering Postdoctoral Fellowship. 2020-2022
First Place Poster Presentation. Vail Scientific Summit for Regenerative Medicine. 2019
National Defense Science and Engineering Graduate Fellowship. US Dept of Defense. 2015-2018
UC Berkeley Amgen Fellowship in Organic Chemistry. 2013
JA Finbloom, MA Yu, TA Desai. “Engineering material biointerfaces to advance the treatment of cystic fibrosis lung infections.” Virtual oral presentation at the BMES National Meeting. Oct 2021.
JA Finbloom. “Storming bacterial biofilm fortresses with nanotechnology.” Oral presentation at the UCSF Postdoc Slam TED Talk Competition. San Francisco, CA. Sep 2019.
JA Finbloom, KO Rivera, T Miclau, CS Bahney, TA Desai. “Injectable nanowire scaffolds for the treatment and repair of infected open fractures.” Poster presentation at the Vail Scientific Summit on Advances in Regenerative Medicine. Vail, CO. Aug 2019. *Awarded First Prize*
JA Finbloom, TA Desai. “Tunable nanowire scaffolds for regenerative engineering.” Invited oral presentation at the Lawrence Berkeley National Laboratory Molecular Foundry Annual User Meeting. Berkeley, CA. Aug 2019.
JA Finbloom, CC Slack, K Han, DE Wemmer, A Pines, MB Francis. “Rotaxane probes for applications in molecular detection with Xe hyperCEST NMR.” Oral presentation at the ACS National Meeting. San Francisco, CA. Apr 2017.
Dr. Finbloom attended the 2021 Lindau Nobel Laureate Meeting on Interdisciplinary Research. Young scientists and Nobel laureates met to discuss new approaches to interdisciplinary research. Due to COVID-19, the 2021 meeting was held online, and Dr. Finbloom was invited to attend the 2022 Chemistry Meeting in person. https://postdocs.ucsf.edu/news/four-ucsf-learners-selected-lindau-nobel-...
Dr. Finbloom is one of three postdocs selected for the inaugural cohort of UCSF Health Innovation Via Engineering Fellows. https://pharmacy.ucsf.edu/news/2020/03/ucsfs-first-engineering-fellowshi...
Dr. Joel Finbloom is an Assistant Professor within the Nanomedicine and Chemical Biology research theme at the Faculty of Pharmaceutical Sciences. The Finbloom lab designs bioinspired materials that interface with microbial communities to advance human health. By working at the intersection of chemical biology, nanotechnology, and bioengineering, the Finbloom lab will tackle critical challenges in the pharmaceutical sciences - treating antibiotic resistant bacterial infections and improving the oral delivery of probiotics.
Dr. Finbloom started his scientific career at the NIH in 2008, where he worked for four summers in the National Institute of Allergy and Infectious Diseases under the mentorship of Dr. Kathryn Zoon. Dr. Finbloom received his BA in chemistry in 2013 from Northwestern University, while conducting research in the laboratory of Professor Samuel Stupp. There, Dr. Finbloom developed stimuli-responsive peptide nanomaterials for cancer drug delivery. Dr. Finbloom earned his PhD in chemistry in 2018 from the University of California Berkeley, working in the lab of Professor Matthew Francis to combine the fields of biomaterials and chemical biology for applications in protein modification and nanomedicine. Dr. Finbloom then completed a postdoctoral fellowship in the laboratory of Professor Tejal Desai at the University of California San Francisco, where he developed nanomaterials-based strategies for antimicrobial drug delivery and regenerative medicine. A central theme throughout Dr. Finbloom’s interdisciplinary research is how to better design the physicochemical properties of nanomaterials to direct interactions with biological systems and improve biomedical applications.